These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24950059)

  • 1. BRCA1 haploinsufficiency leads to altered expression of genes involved in cellular proliferation and development.
    Feilotter HE; Michel C; Uy P; Bathurst L; Davey S
    PLoS One; 2014; 9(6):e100068. PubMed ID: 24950059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific.
    Chehade R; Pettapiece-Phillips R; Salmena L; Kotlyar M; Jurisica I; Narod SA; Akbari MR; Kotsopoulos J
    Breast Cancer Res; 2016 Aug; 18(1):87. PubMed ID: 27534398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells.
    Konishi H; Mohseni M; Tamaki A; Garay JP; Croessmann S; Karnan S; Ota A; Wong HY; Konishi Y; Karakas B; Tahir K; Abukhdeir AM; Gustin JP; Cidado J; Wang GM; Cosgrove D; Cochran R; Jelovac D; Higgins MJ; Arena S; Hawkins L; Lauring J; Gross AL; Heaphy CM; Hosokawa Y; Gabrielson E; Meeker AK; Visvanathan K; Argani P; Bachman KE; Park BH
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17773-8. PubMed ID: 21987798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 haploinsufficiency: consequences for breast cancer.
    Salmena L; Narod S
    Womens Health (Lond); 2012 Mar; 8(2):127-9. PubMed ID: 22375716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair capacity is impaired in healthy BRCA1 heterozygous mutation carriers.
    Vaclová T; Gómez-López G; Setién F; Bueno JM; Macías JA; Barroso A; Urioste M; Esteller M; Benítez J; Osorio A
    Breast Cancer Res Treat; 2015 Jul; 152(2):271-82. PubMed ID: 26071757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).
    El Ansari FZ; Jouali F; Marchoudi N; Bennani MM; Ghailani NN; Barakat A; Fekkak J
    BMC Cancer; 2020 Aug; 20(1):747. PubMed ID: 32778078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
    Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
    Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population.
    Lavie O; Narod S; Lejbkowicz F; Dishon S; Goldberg Y; Gemer O; Rennert G
    Ann Oncol; 2011 Apr; 22(4):964-966. PubMed ID: 20924075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
    Casey MJ; Bewtra C
    Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.
    Welcsh PL; King MC
    Hum Mol Genet; 2001 Apr; 10(7):705-13. PubMed ID: 11257103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased proliferative background in healthy women with BRCA1/2 haploinsufficiency is associated with high risk for breast cancer.
    Nisman B; Kadouri L; Allweis T; Maly B; Hamburger T; Gronowitz S; Peretz T
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2110-5. PubMed ID: 23966579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence.
    Sedic M; Skibinski A; Brown N; Gallardo M; Mulligan P; Martinez P; Keller PJ; Glover E; Richardson AL; Cowan J; Toland AE; Ravichandran K; Riethman H; Naber SP; Näär AM; Blasco MA; Hinds PW; Kuperwasser C
    Nat Commun; 2015 Jun; 6():7505. PubMed ID: 26106036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
    Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
    Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
    Speit G; Trenz K
    Cytogenet Genome Res; 2004; 104(1-4):325-32. PubMed ID: 15162060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
    Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
    PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-expression profiles in hereditary breast cancer.
    Hedenfalk I; Duggan D; Chen Y; Radmacher M; Bittner M; Simon R; Meltzer P; Gusterson B; Esteller M; Kallioniemi OP; Wilfond B; Borg A; Trent J; Raffeld M; Yakhini Z; Ben-Dor A; Dougherty E; Kononen J; Bubendorf L; Fehrle W; Pittaluga S; Gruvberger S; Loman N; Johannsson O; Olsson H; Sauter G
    N Engl J Med; 2001 Feb; 344(8):539-48. PubMed ID: 11207349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.